Physician profile
Jay H Chappell
NPI 1659379824
$11,868.75
in general payments reported to CMS, 2019-2025
25 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,611 · 2020: $2,050 · 2021: $1,059 · 2022: $1,058 · 2023: $1,486 · 2024: $2,998 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Food and Beverage: $2,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,090.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,064.76 | 2019-2025 | Accent, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Edwards Lifesciences Corporation | $573.53 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novartis Pharmaceuticals Corporation | $415.64 | 2019-2025 | |
| Medtronic Vascular, INC. | $259.37 | 2019-2020 | |
| Medtronic, INC. | $178.91 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $142.19 | 2019-2024 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $127.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $126.46 | 2019-2025 | Eliquis |
| Pfizer INC. | $110.01 | 2019-2024 | |
| Inari Medical, INC. | $98.58 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $97.97 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $93.36 | 2020-2025 | Lifevest |
| Abiomed | $79.48 | 2023-2024 | Impella |
| Celgene Corporation | $71.41 | 2022-2023 | Eliquis |
| Amarin Pharma, INC. | $71.20 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $56.42 | 2019-2020 | |
| Exact Sciences Corporation | $50.76 | 2025 | The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.81 | 2023-2025 | Jardiance |
| Irhythm Technologies, INC. | $36.29 | 2024 | Zio Monitor, Zio Xt Patch |
| Kowa Pharmaceuticals America, INC. | $36.21 | 2019 | |
| Alnylam Pharmaceuticals INC. | $29.92 | 2023-2024 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $28.44 | 2019 | |
| Shockwave Medical, INC | $27.62 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Medicomp INC | $24.09 | 2023 | Telepatch Cardiac Monitor |
| Novo Nordisk INC | $19.77 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Chappell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.